Seeking Alpha

NKTR
Nektar Therapeutics - NASDAQ

4/19/2014, 6:07 AM ET
Quote & Analysis Breaking News StockTalk
nktr chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
NKTR vs. ETF Alternatives
Company Description

Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.

Sector: Healthcare
Industry: Biotechnology
Country: United States